An Early Bactericidal Activity, Safety and Tolerability of GSK3036656 in Subjects With Drug-sensitive Pulmonary Tuberculosis
Condition(s):TuberculosisLast Updated:October 26, 2023Completed
Hide Studies Not Open or Pending
Condition(s):TuberculosisLast Updated:October 26, 2023Completed
Condition(s):Pulmonary TuberculosisLast Updated:April 26, 2017Completed
Condition(s):Treatment-naïve, Sputum Smear-positive Patients With Drug-sensitive Pulmonary TBLast Updated:September 10, 2019Completed
Condition(s):Pulmonary TuberculosisLast Updated:March 7, 2007Completed
Condition(s):Pulmonary TuberculosisLast Updated:May 15, 2017Completed
Condition(s):TuberculosisLast Updated:February 22, 2024Recruiting
Condition(s):Pulmonary TuberculosisLast Updated:November 28, 2022Completed
Condition(s):Pulmonary TuberculosisLast Updated:September 13, 2018Completed
Condition(s):Pulmonary TuberculosisLast Updated:June 9, 2023Completed
Condition(s):Tuberculosis, Pulmonary, Drug Sensitive; Tuberculosis, Pulmonary, Multi Drug-resistantLast Updated:March 26, 2019Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.